Department of Virology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
BMC Infect Dis. 2022 May 31;22(1):505. doi: 10.1186/s12879-022-07478-0.
Coronavirus-2019 (COVID-2019) is a novel coronavirus known as Acute Respiratory Syndrome (SARS-CoV-2). The premier standard test for SARS-CoV-2 diagnosis is a one-step RT-qPCR method, which requires specific probes and reagents. Therefore, detection on a large scale is expensive and cannot be very accurate.
A cost-effective technique based on SYBR green was evaluated in the current study. The specific primers for S and N genes were designed, then performed the cross-reactivity test with other coronavirus and respiratory viruses positive samples. Moreover, the analytical sensitivity test was carried out with 8 dilutions (1:10). Lastly, the SARS-CoV-2 clinical samples (n = 210) were tested by these two methods, and receiver operating characteristic (ROC) analysis was performed to investigate the incremental diagnostic value of each gene in the study methods.
The two-step method detected up to 6th dilutions of the SARS-CoV-2 samples and did not show any amplification of the positive samples of other respiratory viruses. ROC analysis revealed a diagnostic ability of the two-step method for SARS-CoV-2 with an area under the ROC curve of ≥ 0.7 (P ˂ 0.05) and relatively high sensitivity and specificity. The combination of N and S genes increased the sensitivity up to 88%, specificity up to 86%, and area under the ROC curve up to 0.85 (95% confidence interval (95% CI) 0.72 to 0.93, P = 0.0461).
Our findings indicated that the two-step method has comparable sensitivity and specificity to the one-step method. Therefore, this method can be considered a potential diagnostic method for diagnosing and monitoring COVID-19 patients. It suggests that when the one-step RT-qPCR method is not available, the two-step RT-qPCR can be used to identify SARS-CoV-2.
新型冠状病毒 2019(COVID-19)是一种被称为严重急性呼吸系统综合征(SARS-CoV-2)的新型冠状病毒。SARS-CoV-2 的主要标准诊断测试是一步式 RT-qPCR 方法,该方法需要特定的探针和试剂。因此,大规模检测既昂贵又不太准确。
本研究评估了一种基于 SYBR 绿的具有成本效益的技术。设计了用于 S 和 N 基因的特异性引物,然后对其他冠状病毒和呼吸道病毒阳性样本进行了交叉反应测试。此外,还进行了 8 个稀释度(1:10)的分析灵敏度测试。最后,用这两种方法检测了 210 例 SARS-CoV-2 临床样本,并进行了接收者操作特性(ROC)分析,以研究研究方法中每个基因的增量诊断价值。
两步法可检测到 SARS-CoV-2 样本的第 6 个稀释度,且未对其他呼吸道病毒的阳性样本进行任何扩增。ROC 分析显示,两步法检测 SARS-CoV-2 的诊断能力具有 ROC 曲线下面积≥0.7(P<0.05),且具有较高的灵敏度和特异性。N 和 S 基因的组合将灵敏度提高到 88%,特异性提高到 86%,ROC 曲线下面积提高到 0.85(95%置信区间 0.72 至 0.93,P=0.0461)。
我们的研究结果表明,两步法与一步法具有可比的灵敏度和特异性。因此,该方法可被视为诊断和监测 COVID-19 患者的潜在诊断方法。这表明在无法使用一步式 RT-qPCR 方法时,可以使用两步式 RT-qPCR 来识别 SARS-CoV-2。